Pore-enhanced reactive oxygen species generation by using covalent organic frameworks for improving sonodynamic therapy of cancer
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Covalent Organic Framework Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (53)
Show source-provided references
1. Reactive oxygen species (ROS)-based nanomedicine10.1021/acs.chemrev.8b00626 ↗
2. Signal transduction by reactive oxygen species10.1083/jcb.201102095 ↗
3. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents10.1038/s41580-020-0230-3 ↗
4. Activation of apoptosis signalling pathways by reactive oxygen species
5. Micro/Nanoparticle-augmented sonodynamic therapy (SDT): breaking the depth shallow of photoactivation10.1002/adma.201602012 ↗
6. Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment10.2147/IJN.S140462 ↗
7. Enhancing penetration ability of semiconducting polymer nanoparticles for sonodynamic therapy of large solid tumor10.1002/advs.202104125 ↗
8. Tumor microenvironment-regulated and reported nanoparticles for overcoming the self-confinement of multiple photodynamic therapy10.1021/acs.nanolett.0c02272 ↗
9. Synthesis of copper peroxide nanodots for H2O2 self-supplying chemodynamic therapy10.1021/jacs.9b03457 ↗
10. Covalent organic polymers based on fluorinated porphyrin as oxygen nanoshuttles for tumor hypoxia relief and enhanced photodynamic therapy10.1002/adfm.201804901 ↗
11. A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer via synergistic ROS augment and autophagy blockage10.1016/j.nantod.2023.101798 ↗
12. An open source and reduce expenditure ROS generation strategy for chemodynamic/photodynamic synergistic therapy10.1038/s41467-020-15591-4 ↗
13. Enhanced chemodynamic therapy by Cu–Fe peroxide nanoparticles: tumor microenvironment-mediated synergistic fenton reaction10.1021/acsnano.1c09171 ↗
14. Singlet oxygen in a cell: spatially dependent lifetimes and quenching rate constants10.1021/ja807484b ↗
15. Porous, crystalline, covalent organic frameworks
16. Regenerable and stable sp2 carbon-conjugated covalent organic frameworks for selective detection and extraction of uranium10.1038/s41467-020-14289-x ↗
17. Covalent organic framework–covalent organic framework bilayer membranes for highly selective gas separation10.1021/jacs.8b05136 ↗
18. Core-shell motif construction: Highly graphitic nitrogen-doped porous carbon electrocatalysts using MOF-derived carbon@COF heterostructures as sacrificial templates10.1016/j.cej.2020.125154 ↗
19. Nitrogen-rich covalent organic frameworks with multiple carbonyls for high-performance sodium batteries10.1038/s41467-019-13739-5 ↗
20. Light-activated hypoxia-sensitive covalent organic framework for tandem-responsive drug delivery10.1021/acs.nanolett.1c00488 ↗
21. A glycosylated covalent organic framework equipped with BODIPY and CaCO3 for synergistic tumor therapy10.1002/anie.202008055 ↗
22. Imparting multi-functionality to covalent organic framework nanoparticles by the dual-ligand assistant encapsulation strategy10.1038/s41467-021-24838-7 ↗
23. In vivo therapeutic response monitoring by a self-reporting upconverting covalent organic framework nanoplatform10.1039/C9SC04875H ↗
24. Covalent organic framework for enhancing chemodynamic therapy via redox dyshomeostasis10.1002/smll.202101368 ↗
25. Etching bulk covalent organic frameworks into nanoparticles of uniform and controllable size by the molecular exchange etching method for sonodynamic and immune combination antitumor therapy10.1002/adma.202205924 ↗
26. Synthesis of CaCO3-based nanomedicine for enhanced sonodynamic therapy via amplification of tumor oxidative stress10.1016/j.chempr.2020.02.020 ↗
27. Upconverted metal-organic framework janus architecture for near-infrared and ultrasound co-enhanced high performance tumor therapy10.1021/acsnano.1c04280 ↗
28. Enhancement of chemical stability and crystallinity in porphyrin-containing covalent organic frameworks by intramolecular hydrogen bonds10.1002/anie.201306775 ↗
29. Metalloporphyrin complex‐based nanosonosensitizers for deep‐tissue tumor theranostics by noninvasive sonodynamic therapy10.1002/smll.201804028 ↗
30. Optimization of triplet excited state and singlet oxygen quantum yields of picolylamine-porphyrin conjugates through zinc insertion10.1021/jp407524w ↗
31. Mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular delivery10.1038/s41467-021-22594-2 ↗
32. Live macrophage-delivered doxorubicin-loaded liposomes effectively treat triple-negative breast cancer10.1021/acsnano.2c03573 ↗
33. Controllable mixed-charged co-assembly of dendritic lipopeptides into invisible capsid-like nanoparticles as potential drug carriers10.1039/D0CC07953G ↗
34. A minimalist dendrimer nanodrug for autophagy inhibition-amplified tumor photothermo-immunotherapy10.1016/j.nantod.2023.101936 ↗
35. An adenosine triphosphate-responsive autocatalytic fenton nanoparticle for tumor ablation with self-supplied H2O2 and acceleration of Fe(III)/Fe(II) conversion10.1021/acs.nanolett.8b03178 ↗
36. Chemodynamic therapy via fenton and fenton‐like nanomaterials: strategies and recent advances10.1002/smll.202103868 ↗
37. A Forward vision for chemodynamic therapy: issues and opportunities
38. Perfluorocarbon loaded fluorinated covalent organic polymers with effective sonosensitization and tumor hypoxia relief enable synergistic sonodynamic-immunotherapy10.1016/j.biomaterials.2021.121250 ↗
39. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?10.1038/nrd2803 ↗
40. Chemodynamic therapy: tumour microenvironment‐mediated fenton and fenton‐like reactions10.1002/anie.201805664 ↗
41. Self‐supply of O2 and H2O2 by a nanocatalytic medicine to enhance combined chemo/chemodynamic therapy10.1002/advs.201902137 ↗
42. Enhanced chemodynamic therapy and immunotherapy by hypoxia augmentation for tumor ablation10.1016/j.nantod.2023.101899 ↗
43. Nanocatalysts‐augmented and photothermal‐enhanced tumor‐specific sequential nanocatalytic therapy in both NIR‐I and NIR‐II biowindows
44. Boosting B cell and macrophage‐mediated humoral immunity with fusion nanovesicles for triple‐negative breast cancer combined therapy10.1002/adhm.202202209 ↗
45. Understanding the Warburg effect: the metabolic requirements of cell proliferation10.1126/science.1160809 ↗
46. Ferroptosis: an iron-dependent form of nonapoptotic cell death10.1016/j.cell.2012.03.042 ↗
47. CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy10.1038/s41586-019-1170-y ↗
48. Regulation of ferroptotic cancer cell death by GPX410.1016/j.cell.2013.12.010 ↗
49. Mito‐bomb: targeting mitochondria for cancer therapy10.1002/adma.202007778 ↗
50. Near-infrared light-initiated molecular superoxide radical generator: rejuvenating photodynamic therapy against hypoxic tumors10.1021/jacs.8b08658 ↗
51. The mitochondrion in apoptosis: how Pandora’s box opens10.1038/35048073 ↗
52. Covalent organic frameworks as favorable constructs for photodynamic therapy10.1002/anie.201909020 ↗
53. A COF-based nanoplatform for highly efficient cancer diagnosis, photodynamic therapy and prognosis10.1039/D0SC00847H ↗